Veery Capital, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1844375 Wilmington, DE

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$294,372

-$35,795 QoQ

Shares Held

2,330

-1.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#1,661

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Veery Capital, LLC holds $1,998,644 across 6 Drug Manufacturers - General names. GILD ranks #5 (14.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,691	$429,463
2	LLY	ELI LILLY & Co	308	$369,424
3	MRK	Merck & Co., Inc.	2,664	$342,324
4	AZN	Astrazeneca PLC	1,787	$338,850
5	GILD	Gilead Sciences, Inc. This page	2,330	$294,372
6	ABBV	AbbVie Inc.	891	$224,211

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$294,372	2,330	-1.6%	Shares	Sole	2026-07-09
2026-03-31	$330,167	2,369	-2.1%	Shares	Sole	2026-04-09
2025-12-31	$297,153	2,421	+1.9%	Shares	Sole	2026-01-27
2025-09-30	$263,625	2,375	-3.1%	Shares	Sole	2025-10-15
2025-06-30	$271,742	2,451	-2.0%	Shares	Sole	2025-07-07
2025-03-31	$280,237	2,501	—	Shares	Sole	2025-04-08
No filing history on record for this holder in this stock.